Propanc Biopharma, Inc. (PPCB)
Propanc Biopharma Market Cap: 4.190M for Jan. 16, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Lumos Diagnostics Holdings Ltd. | 153.50M |
| Incannex Healthcare, Inc. | 130.53M |
| NovaBay Pharmaceuticals, Inc. | 1.861B |
| Palatin Technologies, Inc. | 16.31M |
| Theriva Biologics, Inc. | 6.586M |
Market Cap Related Metrics
| Price to Book Value | 0.2917 |
| Price | 0.3135 |
| Earnings Yield | -14.75K% |